Worsening Heart Failure: An Opportunity for Treatment Implementation Even With a Preserved Ejection Fraction?

Competing Interests: Funding Support and Author Disclosures Dr Lindberg has received personal fees from AstraZeneca outside of the submitted work. Dr Savarese has received grants and personal fees from CSL Vifor, Boehringer Ingelheim, AstraZeneca, Servier, Novartis, Cytokinetics, and Pharmacosmos; has received personal fees from Roche, Abbott, Edwards Lifesciences, Medtronic, TEVA, Menarini, INTAS, GETZ, and Hikma; and has received grants from Boston Scientific, Merck, and Bayer, all outside of the submitted work.